Neuroendocrine Control of Follicle-Stimulating Hormone (FSH) Secretion: II. Is Follistatin-Induced Suppression of FSH Secretion Mediated via Changes in Activin Availability and Does It Involve Changes in Gonadotropin-Releasing Hormone Secretion?1
Neuroendocrine Control of Follicle-Stimulating Hormone (FSH) Secretion: II. Is Follistatin-Induced Suppression of FSH Secretion Mediated via Changes in Activin Availability and Does It Involve Changes in Gonadotropin-Releasing Hormone Secretion?1
复制标题
卵泡刺激素 (FSH) 分泌的神经内分泌控制:II。
DOI:
--
复制
发表时间:
2002
影响因子:
3.6
通讯作者:
J. V. Van Cleeff
中科院分区:
文献类型:
--
作者:
V. Padmanabhan;D. Battaglia;Morton B. Brown;F. Karsch;James S. Lee;Wenqin Pan;D. Phillips;J. V. Van Cleeff
Abstract The objective of the present study was to determine to what extent activin participates in setting the level of FSH secretion and if this regulation includes mediation via changes in GnRH secretion. We administered follistatin, the high-affinity binding protein for activin, to five ovariectomized sheep; we reasoned that the resultant binding of follistatin to activin should lower activin bioavailability and FSH secretion. Hypophyseal portal and peripheral blood samples were collected simultaneously at 10-min intervals for 18 h to measure GnRH, LH, FSH, and both activin-free and total follistatin. Six hours into collection, each ewe received 150 μg/kg i.v. of recombinant human follistatin-288. A week later, the same ewes were subjected to a second series of blood collections of similar length (time control). The FSH levels in pituitary portal blood were approximately 8-fold higher than those in the peripheral circulation. The FSH secretory patterns changed minimally during the time-control period. In contrast, follistatin had profound suppressive effects on FSH secretion. Maximal FSH suppression after FS-288 administration occurred at 5–6 h in the pituitary portal (65% suppression) and 9–10 h in the peripheral (48% suppression) circulation. Follistatin had no effect on GnRH or LH secretory patterns. Disappearance of total follistatin (i.e., free follistatin plus activin-bound follistatin) from the circulation was slower (P < 0.05) than that of free follistatin alone, suggesting that some of the follistatin was complexed with circulating activin, thus reducing the bioavailability of activin. The slower clearance of total follistatin and the lack of follistatin effects on GnRH secretion suggest that changes in activin bioavailability dictate the level of pituitary FSH secretion and that this is a pituitary-specific effect.
登录
查看更多内容
影响因子:
3.6
作者:
Depaolo,LV;Shimonaka,M;Ling,N
通讯作者:
Ling,N
DOI:
10.1093/humrep/15.5.1052
发表时间:
2000
期刊:
Human reproduction (Oxford, England)
影响因子:
--
作者:
Foster,CM;Phillips,DJ;Wyman,T;Evans,LW;Groome,NP;Padmanabhan,V
通讯作者:
Padmanabhan,V
影响因子:
20.3
作者:
Alfredo Ulloa-Aguirre;A. Midgley;I. Beitins;I. Beitins;Vasantha Padmanabhan
通讯作者:
Alfredo Ulloa-Aguirre;A. Midgley;I. Beitins;I. Beitins;Vasantha Padmanabhan
影响因子:
4.8
作者:
Huey-Jing Huang;Joyce C. Wu;P. Su;Oksana V. Zhirnov;William L. Miller
通讯作者:
Huey-Jing Huang;Joyce C. Wu;P. Su;Oksana V. Zhirnov;William L. Miller
DOI:
10.1210/endo.139.8.6125
发表时间:
1998
期刊:
Endocrinology.
影响因子:
--
作者:
Ramaswamy,S;Pohl,CR;McNeilly,AS;Winters,SJ;Plant,TM
通讯作者:
Plant,TM